Innovation & intellectual property · 10/06/2016Updated: 10/17/2026 · 1 min read
U.S. Patent Office Grants Interim Extension for LOCILEX Patent
Summary
The U.S. Patent and Trademark Office has issued an order granting a one-year interim extension of the term for U.S. Patent No. 5,912,231, which covers the medication LOCILEX (pexiganan).
Original source language: Federal Register — Patent and Trademark OfficeOpen original release →